These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37968055)

  • 1. Community-friendly tool to assess patient satisfaction in tuberculosis programme in the covid pandemic period; Bhubaneswar; India.
    Kar S; Menberu M; Priyadarshini P; Sahu KS; Behera MR
    Indian J Tuberc; 2023 Oct; 70(4):483-488. PubMed ID: 37968055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patient-centered medicine for tuberculosis medical services].
    Fujita A; Narita T
    Kekkaku; 2012 Dec; 87(12):795-808. PubMed ID: 23350521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is tuberculosis epidemic riding upon the waves of COVID-19 pandemic? A time-trend study from South India.
    Revendran J; Verma G; Jose JA; Prasana R; Kishan KR; Thanigaiarasu N
    Int J Mycobacteriol; 2023; 12(4):463-466. PubMed ID: 38149544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.
    Mergenthaler C; Bhatnagar A; Dong D; Kumar V; Lakis C; Mutasa R; Dapkekar S; Sahore A; Surendran S; Fritsche G; Sachdeva KS; Dieleman M
    BMC Health Serv Res; 2024 Aug; 24(1):907. PubMed ID: 39113002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National TB elimination programme - What has changed.
    Khanna A; Saha R; Ahmad N
    Indian J Med Microbiol; 2023; 42():103-107. PubMed ID: 36402676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid DOTS expansion in India.
    Khatri GR; Frieden TR
    Bull World Health Organ; 2002; 80(6):457-63. PubMed ID: 12132002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TB free India: Reaching the unreached tribal population under National Tuberculosis Elimination Programme.
    Bhat J; Rao R; Kumar R; Yadav R; Singh P; Rao VG; Das A
    Indian J Tuberc; 2022 Jan; 69(1):4-7. PubMed ID: 35074149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of tuberculosis in homes for the aged and orphanages of a district in Kerala, India.
    Nujum ZT; S S; Rakesh PS; G R; U A
    Indian J Tuberc; 2024 Apr; 71(2):130-136. PubMed ID: 38589116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisions in TB programme - boon or bane? A qualitative study exploring barriers and facilitators among health care workers in private and public sector, Kerala.
    Mathew G; Kumar SCS; Cherian KM; Issac N; Benjamin AI
    Indian J Tuberc; 2021 Jul; 68(3):356-362. PubMed ID: 34099201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis screening for pediatric household contacts in India: Time to adapt newer strategies under the National TB Elimination Programme!
    Chawla K; Burugina Nagaraja S; Siddalingaiah N; Sanju C; Kumar U; Shenoy VP; Shastri S; Singarajipur A
    PLoS One; 2023; 18(10):e0292387. PubMed ID: 37796796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STEPS - a patient centric and low-cost solution to ensure standards of TB care to patients reaching private sector in India.
    Rakesh PS; Balakrishnan S; Sunilkumar M; Alexander KG; Vijayan S; Roddawar V; Pramod Kumar PP; Kailash J; Kunoor A; Rajiv M; John A; Ramachandran R
    BMC Health Serv Res; 2022 Jan; 22(1):2. PubMed ID: 34974843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOTS centre at a tertiary care teaching hospital: lessons learned and future directions.
    Sharma SK; Lawaniya S; Lal H; Singh UB; Sinha PK
    Indian J Chest Dis Allied Sci; 2004; 46(4):251-6. PubMed ID: 15515825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards building a tuberculosis free world.
    Mandal S
    Indian J Tuberc; 2022 Jul; 69(3):259-261. PubMed ID: 35760473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Life Assessment in Diabetic Patients Using a Validated Tool in a Patient Population Visiting a Tertiary Care Center in Bhubaneswar, Odisha, India.
    Meher D; Kar S; Pathak M; Singh S
    ScientificWorldJournal; 2020; 2020():7571838. PubMed ID: 33456400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pandemic on DOTS treatment during COVID-19 lockdown- A cross-sectional study.
    Kabbur S; Patil B; Angolkar M; Narasannavar A
    Indian J Tuberc; 2023 Jul; 70(3):324-328. PubMed ID: 37562908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life among tuberculosis patients under Revised National Tuberculosis Control Programme in rural and urban Puducherry.
    Ramkumar S; Vijayalakshmi S; Seetharaman N; Pajanivel R; Lokeshmaran A
    Indian J Tuberc; 2017 Jan; 64(1):14-19. PubMed ID: 28166911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management for tuberculosis control in Greater London in comparison with that in Osaka City: lessons for improvement of TB control management in Osaka City urban setting.
    Ohkado A; Williams G; Ishikawa N; Shimouchi A; Simon C
    Health Policy; 2005 Jul; 73(1):104-23. PubMed ID: 15911061
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.